Chemotherapy as treatment of primary and recurrent small cell lung cancer
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 33, S99-S107
- https://doi.org/10.1016/s0169-5002(01)00309-9
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- New Chemotherapy Agents for Small Cell Lung CancerChest, 2000
- A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancerBritish Journal of Cancer, 1998
- 1 Phase II trial of navelbine (NVB), in small cell lung cancer (SCLC)Lung Cancer, 1997
- Small Cell Lung CancerChest, 1995
- Activity of docetaxel (Taxotere) in small cell lung cancerEuropean Journal Of Cancer, 1994
- Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)Annals of Oncology, 1994
- Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patientsEuropean Journal Of Cancer, 1993
- Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer: Report to the medical research council by its lung cancer working partyRespiratory Medicine, 1989
- The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinomaCancer, 1979
- Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristineCancer, 1976